Apparent heterogeneous responsiveness of human platelet rich plasma to catecholamines

Platelets

Volumn 14, Issue 3, 2003, Pages 171-178

  Pyo, Mi Kyung ^a,c   Yun Choi, Hye Sook ^a   Hong, Young Jin ^b  

^a Seoul National University   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c ES Life Science Research Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; CLONIDINE; COLLAGEN; DOPAMINE; EPININE; NORADRENALIN;

ADULT; ANIMAL CELL; ARTICLE; CELL HETEROGENEITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; KOREA; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

ADRENERGIC ALPHA-AGONISTS; ADULT; BLOOD PLATELETS; CATECHOLAMINES; CLONIDINE; DEOXYEPINEPHRINE; DOPAMINE; EPINEPHRINE; FEMALE; HUMANS; KINETICS; KOREA; MALE; MIDDLE AGED; NOREPINEPHRINE; PLATELET ADHESIVENESS;

ANIMALIA;

EID: 0038627709     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953710031000092785     Document Type: Article

References (51)

1. 2-adrenoceptors primarily responsible for inducing human platelet aggregation. Nature 1979; 277: 659-61.
2. Lasch P, Jakobs K H. Agonistic and antagonistic effects of various α-adrenergic agonists in human platelets. Naunyn Schmiedebergs Arch Pharmacol 1979; 306: 119-25.
3. 3H]phentolamine. Mol Pharmacol 1979; 16: 719-28.
4. 3H]yohimbine. Biochem Biophysics Res Commun 1980; 97: 1562-70.
5. 3H]clonidine. Mol Pharmacol 1981; 19: 179-83.
6. 3H]Dihydroergoeryptine binding to α-adrenergic receptors in human platelets. Biochem Pharmacol 1982; 31(16): 2591-7.
7. O'Brien J R. Some effects of adrenaline and anti-adrenaline compounds in human platelets in vitro and in vivo. Nature 1963; 200: 763-4.
8. Hsu C Y, Knapp D R, Halushka P V. The effects of alpha adrenergic agents on human platelet aggregation. J Pharmacol Exp Ther 1979; 208: 366-70.
9. Lanza F, Beretz A, Stierle A, Hanau D, Kubina M, Cazenave J P. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol 1988; 255: H1276-88.
10. Steen V M, Tysnes O B, Holmsen H. Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism. Biochem J 1988; 253: 581-6.
11. 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. Thromb Haemost 1993; 70(3): 506-13.
12. Sinakos Z, Caen J P. Platelet aggregation in mammalians (human, rat, rabbit, guinea-pig, horse, dog). A comparative study. Thrombos Diath Haemorrh (Stuttgart) 1967; 17: 99-111.
13. Yu S K, Latour J G. Potentiation by α and inhibition by β-adrenergic stimulation of rat platelet aggregation. A comparative study with human and rabbit platelets. Thromb Haemostas (Stuttgart) 1977; 37: 413-22.
14. Kerry R, Scrutton M C, Wallis R B. Mammalian platelet adrenoceptors. Br J Pharmacol 1984; 81: 91-102.
15. Meyers K M, Huston L Y, Clemmons R M. Regulation of canine platelet function. II. Catecholamines. Am J Physiol 1983; 245: R100-9.
16. Beatty C H, Howard Jr. C F, Caruso V. Potentiation with epinephrine of macaque platelet aggregation by other agonists: Implications for studies on human atherosclerosis. Thromb Res 1986; 41: 447-58.
17. 2-adrenorceptors inhibits epinephrine-induced canine platelet aggregation. Arch Int Pharmacodyn Ther 1991; 310: 56-65.
18. Hikasa Y, Abe M, Satoh T, Hisashi Y, Ogasawara S, Matsuda H. Effects of imidazoline and non-imidazoline α-adrenergic agents on canine platelet aggregation. Pharmacology 1999; 58: 171-82.
19. Kerry R, Scrutton M C. Platelet beta-adrenorceptors. Br J Pharmacol 1983; 79(3): 681-91.
20. Winther K, Klysner R, Geisler A, Andersen P H. Characterization of human platelet β-adrenoceptors. Thromb Res 1985; 40: 757-67.
21. 125I-iodopindolol binding. J Cyclic Nucleotide Protein Phosphor Res 1985; 10: 439-50.
22. Kerry R, Scrutton M C. Platelet β-adrenoceptors. Br J Pharmacol 1983; 79: 681-91.
23. 2-Adrenoceptors activate nitric oxide synthase in human platelets. Circ Res 2000; 87: 39-44.
24. O'Brien, J R. Variability in the aggregation of human platelet by adrenaline. Nature 1964; 202: 1188-90.
25. Kaywin P, McDonough M, Insel P A, Shattil S J. Platelet function in essential thrombocytemia: decreased epinephrine responsiveness associated with a deficiency of platelet alpha 2 adrenergic receptors. New Eng J Med 1978; 299: 505-9.
26. Cardamone J M, Edson J R, McArthur J R, Jacob H S. Abnormalities of platelet function in the myeloproliferative disorders. J Amer Med Assoc 1972; 221: 270-3.
27. O'Regan S, Rivard G E, Cole C, Robitaille P O. Platelet hyporesponsiveness to epinephrine in carriers of Bartter's syndrom. Prostagrandins Med 1979; 2: 321-4.
28. Tamponi G, Pannochia A, Arduino C, Bazzan M, Della Dora N D, Schinco P et al. Congenital deficiency of alpha-2-adrenoceptors on human platelets: description of two cases. Thromb Haemost 1987; 58: 1012-6.
29. Rao A K, Willis J, Kowalska M A, Wachtfogel Y T, Colman R W. Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine, Studies of a familial platelet alpha 2 adrenergic receptor defect. Blood 1988; 71: 494-501.
30. Scrutton, M C, Clare K A, Hutton, R A, Bruckdorfer K R. Depressed responsiveness to adrenaline in platelets from appearently normal human doners:a familial trait. Br J Haematol 1981; 49: 303-14.
31. Kambayashi J, Shinoki N, Nakamura T, Ariyoshi H, Kawasaki T, Sakon M et al. Prevalence of impaired responsiveness to epinephrine in platelets among Japanese. Throms Res 1996; 81(1): 85-90.
32. Ahn C H, Hamada A, Miller D D, Feller D R. α-Adrenoceptor-mediated actions of optical isomers and desoxy analogs of catecholimidazoline and norepinephrine in human platelets: in vitro. Biochem Pharmacol 1986; 35: 4095-102.
33. Ahn C H, Shams G, Schotzinger R L, Miller D D, Feller D R. Stereostructure activity relationships of catecholamines on human platelet function. Proc Soc Exp Biol Med 1990; 194: 149-56.
34. Yun-Choi H S, Park K M, Pyo M K. Epinephrine induced platelet aggregation in rat platelet-rich plasma. Thromb Res 2000; 100: 511-8.
35. 2. Thromb Res 1983; 30(3): 289-96.
36. Yun-Choi H S, Kim S O, Kim J H, Lee J R. Modified smear method for screening potential inhibitors of platelet aggregation from platelet sources. J Nat Prod 1985; 48: 363-70.
37. Born G V R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (London) 1962; 194: 927-9.
38. Smith C C, Curtis L D, Delamothe A P, Prichard B N C, Betteridge D J. The distribution of catecholamines between platelets and plasma in normal human subject. Clin Sci 1985; 69: 1-6.
39. Wilson A P, Smith C C, Prichard B N C, Betteridge D J. Platelet catecholamines and platelet function in normal human subjects. Clin Sci 1987; 73; 99-109.
40. Rosen S G, Sanfield J A, Morrow L A, Zweifler A. J. Relationship between plasma and platelet epinephrine concentration in humans. Am J Physiol 1987; 252: E334-9.
41. Bartsch P. Platelet activation with exercise and risk of cardiac events. Lancet 1999; 354: 1747-8.
42. 2-adrenergic agonist-potentiated platelet activation. Arterioscler Thromb Vasc Biol 1999; 19: 1559-65.
43. Nair, G V, Gurbel, P A, O'Connor C M, Gattis W A, Murugesan, S R, Serebruany V L. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitor. Am J Cardio 1999; 84: 321-3.
44. Anfossi G, Trovati M. Role of catecholamines in platelet funtion: pathophysiological and clinical significance. Eur J Clin Invest 1996; 26: 353-70.
45. Rupp H. Excess catecholamine syndrom: pathophysiology and therapy. Ann N Y Acad Sci 1999; 881: 430-44.
46. 2-adrenoceptor affinity in normal subjects. Am J Cardiol 1989; 63: 1002-5.
47. 2-agonist, suppresses morning elevations in aggregation of human platelets. J Cardiovasc Pharmacol 2001; 37: 89-93.
48. Soloviev M V, Okazaki Y, Harasaki H. Whole blood platelet aggregation in human and animals: A comparative study. J Surg Res 1999; 82: 180-187.
49. Nakamura T, Ariyoshi H, Kambayashi J, Ikeda M, Shinoki N, Kawasaki T, et al. Signal transduction system in epinephrine stimulated platelets; comparison between epinephrine sensitive and insensitive platelets. Thromb Res 1997; 85: 83-93.
50. 2 and adenosine diphosphate in collagen-induced aggregation in man and rat. Br J Pharmacol 1986; 87: 109-15.
51. 2 by the action of collagen on rat platelets. Thromb Res 1987; 46: 425-36.